Ascites reprograms innate lymphoid immune cells in ovarian cancer by promoting ILC2 enrichment and dysfunctional NK-cell states
Journal for ImmunoTherapy of Cancer · 2026-08 · 14 (8) · e015396
DOI: 10.1136/jitc-2026-015396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 26.08.2026. Verfasst von Bilal Alashkar Alhamwe und 11 weiteren Autor:innen. Beteiligte Einrichtung: Marburg University, Institute for Tumor Immunology, Marburg, Germany. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Killer Cells, Natural, Ascites, Immunity, Innate. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Hessisches Ministerium für Wissenschaft und Kunst.
Abstract (Originalsprache)
Background
High-grade serous ovarian cancer (HGSOC) is commonly accompanied by malignant ascites, a clinically relevant tumor niche that promotes immune evasion, metastasis, and treatment resistance. Although natural killer (NK)-cell dysfunction has been described in ovarian cancer, the broader innate lymphoid landscape of ascites and the mechanisms linking ascites-derived signals to innate immune suppression remain insufficiently resolved.
Methods
We performed single-cell RNA sequencing of NK/innate lymphoid cells from ovarian cancer ascites to define cellular heterogeneity and differentiation states. Functional assays assessed NK-cell cytotoxicity, degranulation, and receptor expression following exposure to patient-derived ascites, with or without transforming growth factor-β (TGF-β) receptor inhibition. Proteomic profiling was used to characterize the soluble ascites milieu, and clinical associations were examined for innate lymphoid subsets.
Results
Single-cell analysis identified eight transcriptionally distinct NK/innate lymphoid states, including cytotoxic, precursor, early-like, tolerant/immunoregulatory, regulatory, proinflammatory, and innate lymphoid populations. Ovarian cancer ascites was characterized by depletion of cytotoxic and precursor NK-cell states together with enrichment of early-like, tolerant, regulatory, pro-inflammatory, and innate lymphoid cell (ILC) populations. Trajectory analysis indicated impaired maturation toward terminally differentiated cytotoxic NK cells. Notably, ascites contained an expanded population of programmed cell death protein 1 (PD-1) + ILC2s, which were more abundant in patients with shorter progression-free survival. In functional assays, short-term exposure of healthy donor NK cells to ascites suppressed degranulation and tumor-cell killing, reduced expression of activating receptors including NKp30 and DNAM-1, increased inhibitory receptor expression, and shifted NK cells toward a CD56 high CD16 low phenotype. Proteomic profiling supported a soluble milieu consistent with type 2 immune skewing and NK-cell suppression. Importantly, TGF-β receptor inhibition partially restored NK-cell activation and function in the presence of ascites.
Conclusions
HGSOC ascites establishes a type 2-skewed immunoregulatory niche that coordinately drives NK cell dysfunction and PD-1 + ILC2 accumulation. The findings identify TGF-β-linked suppression and ascites-associated immune regulators as candidate immunotherapeutic vulnerabilities for restoring antitumor immunity in ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Marburg University, Institute for Tumor Immunology, Marburg, Germany.
- Department of Anesthesiology, Critical Care, and Pain Medicine, Cardiac Anesthesia Division, Boston Children's Hospital, Department of Immunology and Anaesthesia, Harvard Medical School, Boston, Massachusetts, USA.
- Core facility Genomics, Marburg University, Marburg, Germany.
- Marburg University, Translational Inflammation Research Division & Core Facility for Single Cell Multiomics, Medical Faculty, Marburg, Germany.
- Marburg University and University Hospital Marburg (UKGM), Institute of Pathology, Marburg, Germany.
- Marburg University, Translational Oncology, Center for Tumor Biology and Immunology (ZTI), Marburg, Germany.
Förderung
- Deutsche Forschungsgemeinschaft
- Hessisches Ministerium für Wissenschaft und Kunst
Zitieren
APA
Alashkar Alhamwe, B., Alhamdan, F., Ponath, V., Hoffmann, N., Meena, C., Fingernagel, F., Garn, H., Pauk, K., Keber, C., Denkert, C., Reinartz, S., & Pogge von Strandmann, E. (2026). Ascites reprograms innate lymphoid immune cells in ovarian cancer by promoting ILC2 enrichment and dysfunctional NK-cell states. Journal for ImmunoTherapy of Cancer, 14(8), e015396. https://doi.org/10.1136/jitc-2026-015396
Vancouver
Alashkar Alhamwe B, Alhamdan F, Ponath V, Hoffmann N, Meena C, Fingernagel F, et al. Ascites reprograms innate lymphoid immune cells in ovarian cancer by promoting ILC2 enrichment and dysfunctional NK-cell states. Journal for ImmunoTherapy of Cancer. 2026;14(8):e015396. doi:10.1136/jitc-2026-015396
BibTeX
@article{AlashkarAlhamwe2026,
author = {Alashkar Alhamwe, Bilal and Alhamdan, Fahd and Ponath, Viviane and Hoffmann, Nathalie and Meena, Celina and Fingernagel, Florian and Garn, Holger and Pauk, Kim and Keber, Corinna and Denkert, Carsten and Reinartz, Silke and Pogge von Strandmann, Elke},
title = {Ascites reprograms innate lymphoid immune cells in ovarian cancer by promoting ILC2 enrichment and dysfunctional NK-cell states},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
volume = {14},
number = {8},
pages = {e015396},
doi = {10.1136/jitc-2026-015396}
}
EUVIMED